Cancer therapy utilizing an adenoviral vector expressing only E1A.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 321, doi. 10.1038/sj.cgt.7700436
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2002 AND VI 9 AND IP 4
Results: 10
1
2
Novel vaccination protocol consisting of injecting MUC1 DNA and nonprimed dendritic cells at the same region greatly enhanced MUC1-specific antitumor immunity in a murine model.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 330, doi. 10.1038/sj.cgt.7700444
- By:
- Publication type:
- Article
3
DNA vaccination with AFP-encoding plasmid DNA prevents growth of subcutaneous AFP-expressing tumors and does not interfere with liver regeneration in mice.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 346, doi. 10.1038/sj.cgt.7700445
- By:
- Publication type:
- Article
4
Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 356, doi. 10.1038/sj.cgt.7700446
- By:
- Publication type:
- Article
5
Effective gene transfer to solid tumors using different nonviral gene delivery techniques: Electroporation, liposomes, and integrin-targeted vector.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 399, doi. 10.1038/sj.cgt.7700454
- By:
- Publication type:
- Article
6
TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 372, doi. 10.1038/sj.cgt.7700448
- By:
- Publication type:
- Article
7
Early gene therapy–induced apoptotic response in BT4C gliomas by magnetic resonance relaxation contrast T<sub>1</sub> in the rotating frame.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 338, doi. 10.1038/sj.cgt.7700450
- By:
- Publication type:
- Article
8
Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 382, doi. 10.1038/sj.cgt.7700452
- By:
- Publication type:
- Article
9
Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 390, doi. 10.1038/sj.cgt.7700453
- By:
- Publication type:
- Article
10
Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 4, p. 365, doi. 10.1038/sj.cgt.7700447
- By:
- Publication type:
- Article